Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Goldlink Bio-Tech Co., Ltd. is a high-tech biotechnology company specializing in the research, development, production, and sales of in vitro diagnostic (IVD) reagents and instruments. The company is best known for its proprietary Quantum Dot Fluorescence Immunoassay (QD-FIA) platform, which provides high-sensitivity and high-precision diagnostic testing for a wide range of clinical applications. Its product portfolio includes rapid diagnostic kits for cardiac markers, inflammatory indicators, hormones, and gastric function markers. Headquartered in Shenzhen, China, Goldlink serves hospitals and clinical laboratories globally, focusing on improving the speed and accuracy of point-of-care testing (POCT).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Goldlink.